News

News
Partner news

Oxford to collaborate with Janssen to map the cellular landscape of immune mediated disorders

Read full story
Partner news

Adicet Bio, Inc. Announces Pricing of $135 Million Public Offering of Common Stock and Concurrent Private Placement

Read full story
JNJ Press releases

Gathering Innovation Strength to Capture New Value Johnson & Johnson is Recognized as the First Foreign-Funded Open Innovation Platform by the Shanghai Municipal Government

Read full story
Partner news

Exonate announces the initiation of Phase Ib/II clinical trial for Diabetic Macular Oedema, as part of its collaboration with Janssen

Read full story
Partner news

AdoRx Therapeutics Announces Collaboration with Johnson & Johnson Innovation to Develop Novel Lung Cancer Therapeutics

Read full story
Partner news

Bavarian Nordic Announces Initiation of Phase 1/2a Clinical Trial of Therapeutic HPV Vaccine Regimen in Collaboration with Janssen

Read full story
In the media

J&J’s Global Head of Communication - External Innovation, on how partnerships are fuelling the company’s vision for a World Without Disease.

Read full story
Partner news

Calypso Biotech BV Secures 20 Million EUR in Series A Financing and Strengthens Team to Develop Anti-IL-15 Therapeutic Antibody for Autoimmune Diseases

Read full story
Partner news

Vor Biopharma Completes $42 Million Series A Financing Round to Advance Lead Cell Therapy Product Candidate for the Treatment of Acute Myeloid Leukemia

Read full story
Partner news

New strategic partners join £9.5 million dementia drug discovery collaboration

Read full story
In the media

Reimagining the future of healthcare with William Hait

Read full story
JNJ Press releases

Johnson & Johnson Innovation Announces S$5.1 Million in World Without Disease Research Grants in Collaboration with A*STAR

Read full story
JNJ Press releases

Johnson & Johnson Innovation Opens JJIPO@Monash as Public-Private Partnering Office to Accelerate Innovation in Australia's Life Science Ecosystem

Read full story
JNJ Press releases

Belgium-Based JLINX Incubator to Transition to Johnson & Johnson Innovation JLABS, Expanding Outreach Across Europe

Read full story
JNJ Press releases

Janssen Enters into Worldwide Collaboration with Theravance Biopharma for oral, Pan-Jak Inhibitor Drug Candidate for the Treatment of Inflammatory Bowel Disease

Read full story